Methionine metabolic pathway in alcoholic liver injury

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 1, 2013, Pages 89-95

  Kharbanda, Kusum K ^a,b  

^a Research Service   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

alcoholic liver disease; betaine; genetic factors; methyltransferases; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

BETAINE; METHIONINE; METHYLTRANSFERASE; S ADENOSYLMETHIONINE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; AMINO ACID METABOLISM; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENZYME ACTIVITY; HEREDITY; HUMAN; LIVER FUNCTION; REVIEW;

AMINOBUTYRATES; BETAINE; BIOLOGICAL MARKERS; CYSTATHIONINE; ETHANOL; HUMANS; LIVER; LIVER DISEASES, ALCOHOLIC; METABOLIC NETWORKS AND PATHWAYS; METHIONINE; S-ADENOSYLMETHIONINE;

EID: 84871863138     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835a892a     Document Type: Review

References (40)

1. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutictargets. Gastroenterology 2011; 141:1572-1585
2. Kharbanda KK. Alcoholic liver disease and methionine metabolism. Sem LiverDis 2009; 29:155-165
3. Ji C. Mechanisms of alcohol-induced endoplasmic reticulum stress and organinjuries. Biochemy Res Int 2012; 2012:216450
4. Halsted CH, Medici V. Aberrant hepatic methionine metabolism and genemethylation in the pathogenesis and treatment of alcoholic steatohepatitis.Int J Hepatol 2012; 2012:959746
5. Prudova A, Bauman Z, Braun A, et al. S-adenosylmethionine stabilizescystathionine beta-synthase and modulates redox capacity. Proc Natl AcadSci USA 2006; 103:6489-6494
6. Kharbanda KK, Mailliard ME, Baldwin CR, et al. Betaine attenuates alcoholicsteatosis by restoring phosphatidylcholine generation via the phosphatidylethanolaminemethyltransferase pathway. J Hepatol 2007; 46:314-321 (Pubitemid 44959154)
7. Shinohara M, Ji C, Kaplowitz N. Differences in betaine- homocysteinemethyltransferase expression, endoplasmic reticulum stress response, andliver injury between alcohol-fed mice and rats. Hepatology 2010; 51:796-805
8. Watson WH, Song Z, Kirpich IA, et al. Ethanol exposure modulates hepatic Sadenosylmethionineand S-adenosylhomocysteine levels in the isolatedperfused rat liver through changes in the redox state of the NADH/NAD(\+)system. Biochim Biophys Acta 2011; 1812:613-618
9. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. Homocysteine in health and disease. In: Carmel R, Jacobsen DW, editors.Cambridge: Cambridge University Press; 2001. pp. 63-78
10. Wang Z, Yao T, Song Z. Involvement and mechanism of DGAT2 upregulationin the pathogenesis of alcoholic fatty liver disease. J Lipid Res 2010;51:3158-3165
11. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartateand its repair system. Biol Pharm Bull 2005; 28:1590-1596 (Pubitemid 41324114)
12. Doyle HA, Zhou J, Wolff MJ, et al. Isoaspartyl posttranslational modificationtriggers antitumor T and B lymphocyte immunity. J Biol Chem 2006;281:32676-32683 (Pubitemid 46036823)
13. Vigneswara V, Lowenson JD, Powell CD, et al. Proteomic identification ofnovel substrates of a protein isoaspartyl methyltransferase repair enzyme.J Biol Chem 2006; 281:32619-32629 (Pubitemid 46036817)
14. Boisvert FM, Cote J, Boulanger MC, Richard S. A proteomic analysis ofarginine-methylated protein complexes. Mol Cell Proteomics 2003; 2:1319-1330
15. Kharbanda KK, Rogers DD 2nd, Mailliard ME, et al. Role of elevatedS-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine.Biochem Pharmacol 2005; 70:1883-1890 (Pubitemid 41612019)
16. Kharbanda KK, Rogers DD 2nd, Beckenhauer HC, et al. Tubercidin- inducedapoptosis via increased hepatocellular levels of S-adenosylhomocysteine isattenuated by betaine administration. Alcohol Clin Exp Res 2005; 29:182A
17. Kharbanda KK, Mailliard ME, Baldwin CR, et al. Accumulation of proteinsbearing atypical isoaspartyl residues in livers of alcohol-fed rats is preventedby betaine administration: effects on protein-L-isoaspartyl methyltransferaseactivity. J Hepatol 2007; 46:1119-1125 (Pubitemid 46669733)
18. Carter WG, Vigneswara V, Atkins R, et al. Proteomic characterization of bothaltered protein level and isoaspartate carboxyl methylation in a model ofalcoholic liver disease. Alcohol Clin Exp Res 2008; 32:343A
19. Osna NA, Donohue TM, White RL, et al. Ethanol and hepatic C viral proteinsregulate interferon signaling in liver cells via impaired methylation of STAT1. Hepatology 2008; 48:327A
20. Kharbanda KK. Role of transmethylation reactions in alcoholic liver disease.World J Gastroenterol 2007; 13:4947-4954 (Pubitemid 47496826)
21. Osna NA, White RL, Donohue TM Jr, et al. Impaired methylation as a novelmechanism for proteasome suppression in liver cells. Biochem Biophys ResCommun 2010; 391:1291-1296
22. Kharbanda KK, Todero SL, King AL, et al. Betaine treatment attenuateschronic ethanol-induced hepatic steatosis and alterations to the mitochondrialrespiratory chain proteome. Int J Hepatol 2012; 2012:962183
23. Watanabe M, Osada J, Aratani Y, et al. Mice deficient in cystathionine betasynthase:animal models for mild and severe homocyst(e)inemia. Proc NatlAcad Sci USA 1995; 92:1585-1589
24. Kluijtmans LA, Boers GH, Kraus JP, et al. The molecular basis of cystathioninebeta-synthase deficiency in Dutch patients with homocystinuria: effect of CBSgenotype on biochemical and clinical phenotype and on response to treatment.Am J Hum Genet 1999; 65:59-67 (Pubitemid 30470449)
25. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions ina murine model of 5,10-methylenetetrahydrofolate reductase deficiency.FASEB J 2003; 17:512-514
26. Adinolfi LE, Ingrosso D, Cesaro G, et al. Hyperhomocysteinemia and theMTHFR C677T polymorphism promote steatosis and fibrosis in chronichepatitis C patients. Hepatology 2005; 41:995-1003 (Pubitemid 40593907)
27. Esfandiari F, Medici V, Wong DH, et al. Epigenetic regulation of hepaticendoplasmic reticulum stress pathways in the ethanol-fed cystathionine betasynthase-deficient mouse. Hepatology 2010; 51:932-941
28. Tsuchiya M, Ji C, Kosyk O, et al. Interstrain differences in liver injury and onecarbonmetabolism in alcohol-fed mice. Hepatology 2012; 56:130-139
29. Martinez-Chantar ML, Corrales FJ, Martinez-Cruz LA, et al. Spontaneousoxidative stress and liver tumors in mice lacking methionine adenosyltransferase1A. FASEB J 2002; 16:1292-1294
30. Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, et al. Loss of the glycineN-methyltransferase gene leads to steatosis and hepatocellular carcinoma inmice. Hepatology 2008; 47:1191-1199 (Pubitemid 351547905)
31. Teng YW, Mehedint MG, Garrow TA, Zeisel SH. Deletion of betaine-homocysteineS-methyltransferase in mice perturbs choline and 1-carbon metabolism,resulting in fatty liver and hepatocellular carcinomas. J Biol Chem2011; 286:36258-36267
32. Tian C, Stokowski RP, Kershenobich D, et al. Variant in PNPLA3 is associatedwith alcoholic liver disease. Nat Genet 2010; 42:21-23
33. Tomasi ML, Iglesias-Ara A, Yang H, et al. S-adenosylmethionine regulatesapurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.Gastroenterology 2009; 136:1025-1036
34. Tomasi ML, Ramani K, Lopitz-Otsoa F, et al. S-adenosylmethionine regulatesdual-specificity mitogen-activated protein kinase phosphatase expression inmouse and human hepatocytes. Hepatology 2010; 51:2152-2161
35. Martinez-Lopez N, Garcia-Rodriguez JL, Varela-Rey M, et al. Hepatomacells from mice deficient in glycine N-methyltransferase have increasedRAS signaling and activation of liver kinase B1. Gastroenterology 2012;143:787-798
36. Martinez-Lopez N, Varela-Rey M, Ariz U, et al. S-adenosylmethionineand proliferation: new pathways, new targets. Biochem Soc Trans 2008;36:848-852
37. Wang YC, Chen YM, Lin YJ, et al. GNMT expression increases hepatic folatecontents and folate-dependent methionine synthase-mediated homocysteineremethylation. Mol Med 2011; 17:486-494
38. Medici V, Peerson JM, Stabler SP, et al. Impaired homocysteine transsulfurationis an indicator of alcoholic liver disease. J Hepatol 2010; 53:551-557
39. Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases.Cochrane Database Syst Rev 2006:CD002235
40. Medici V, Virata MC, Peerson JM, et al. S-adenosyl-L-methionine treatment foralcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.Alcohol Clin Exp Res 2011; 35:1960-1965